OxyContin Maker Purdue Pharma Agrees to Tentative Opioid Lawsuit Settlement

OxyContin maker Purdue Pharma has reached a tentative settlement worth billions of dollars to resolve thousands of lawsuits brought by state and local governments who sued the drug company for its role in the opioid epidemic.

At least 16 state attorneys general said they have not agreed to the deal, NBC News reports.

Under the proposed settlement, the Sackler family, which owns Purdue, would give up control of the company, which would declare bankruptcy. Future revenue from the sale of OxyContin would go into a trust designed to assist communities hard hit by the opioid crisis.

Full story at Partnership for Drug-Free Kids

Published by

Will Savage

Quantum Units Continuing Education provides online CEU training's to licensed professional mental health therapists, counselors, social workers and nurses. Our blog provides updates in the field of news and research related to mental health and substance abuse treatment.